The Influences of COVID-19 on Patients With Chronic Kidney Disease: A Multicenter Cross-Sectional Study

Background: The outbreak of coronavirus disease 2019 (COVID-19) has attracted global attention. During the lockdown period of COVID-19, follow-up of many patients with chronic disease had been interrupted, which brought severe challenges to better management of their disease. This study aimed at exp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zheng Jiang, Jiang Liu, Lei Geng, Zhengxia Zhong, Jiaxing Tan, Dongmei Wen, Ling Zhou, Yi Tang, Wei Qin
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/f1bf1eba372b4244a2d602b3f52134a0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f1bf1eba372b4244a2d602b3f52134a0
record_format dspace
spelling oai:doaj.org-article:f1bf1eba372b4244a2d602b3f52134a02021-12-01T02:43:35ZThe Influences of COVID-19 on Patients With Chronic Kidney Disease: A Multicenter Cross-Sectional Study1664-064010.3389/fpsyt.2021.754310https://doaj.org/article/f1bf1eba372b4244a2d602b3f52134a02021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fpsyt.2021.754310/fullhttps://doaj.org/toc/1664-0640Background: The outbreak of coronavirus disease 2019 (COVID-19) has attracted global attention. During the lockdown period of COVID-19, follow-up of many patients with chronic disease had been interrupted, which brought severe challenges to better management of their disease. This study aimed at exploring the change of illness, daily life, and psychological responses during the COVID-19 pandemic among chronic kidney disease (CKD) patients.Methods: A total of 612 patients were enrolled in this study; 282 patients were categorized into the CKD stage 1–2 group and 330 patients were categorized into the CKD stage 3–5 group. Among two groups, 168 (27.5%) and 177 (28.9%) patients were female with a median age of 42 and 45, respectively. The study was conducted by collecting the questionnaires in five nephrology centers. The questionnaire consisted of assessment of anxiety by using the Self-Rating Anxiety Scale and the influences of COVID-19, which included basic demographic data, the influences of COVID-19 on illness and daily life, as well as the patients' psychological responses during the epidemic.Results: A total of 612 patients were included and divided into two groups according to eGFR. Ninety-six patients (34%) in the CKD stage 1–2 group and 141 patients (42.7%) in the CKD stage 3–5 group had reduced their follow-up frequency (p = 0.031). More patients with CKD stages 1–2 consulted online (25.9%), p = 0.005. Besides, patients in the CKD stage 3–5 group tended to be more anxious about follow-up (p = 0.002), fearful of being infected with COVID-19 (p = 0.009), and more likely to feel symptoms getting worse (p = 0.006). The standard scores of SAS were 48.58 ± 7.082 and 51.19 ± 5.944 in the CKD stage 1–2 group and the CKD stage 3–5 group, respectively (p < 0.001). There were significant differences in the severity of anxiety (p = 0.004).Conclusion: COVID-19 had a greater impact on patients with CKD stages 3–5 than those with stages 1–2 in terms of illness, daily life, and psychological disorder. Patients with CKD stages 3–5 were more anxious during the COVID-19 pandemic.Zheng JiangZheng JiangZheng JiangJiang LiuJiang LiuLei GengLei GengZhengxia ZhongJiaxing TanDongmei WenLing ZhouYi TangWei QinFrontiers Media S.A.articleCOVID-19chronic kidney diseaseself-rating anxiety scale (SAS)psychological responseonline consultationPsychiatryRC435-571ENFrontiers in Psychiatry, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
chronic kidney disease
self-rating anxiety scale (SAS)
psychological response
online consultation
Psychiatry
RC435-571
spellingShingle COVID-19
chronic kidney disease
self-rating anxiety scale (SAS)
psychological response
online consultation
Psychiatry
RC435-571
Zheng Jiang
Zheng Jiang
Zheng Jiang
Jiang Liu
Jiang Liu
Lei Geng
Lei Geng
Zhengxia Zhong
Jiaxing Tan
Dongmei Wen
Ling Zhou
Yi Tang
Wei Qin
The Influences of COVID-19 on Patients With Chronic Kidney Disease: A Multicenter Cross-Sectional Study
description Background: The outbreak of coronavirus disease 2019 (COVID-19) has attracted global attention. During the lockdown period of COVID-19, follow-up of many patients with chronic disease had been interrupted, which brought severe challenges to better management of their disease. This study aimed at exploring the change of illness, daily life, and psychological responses during the COVID-19 pandemic among chronic kidney disease (CKD) patients.Methods: A total of 612 patients were enrolled in this study; 282 patients were categorized into the CKD stage 1–2 group and 330 patients were categorized into the CKD stage 3–5 group. Among two groups, 168 (27.5%) and 177 (28.9%) patients were female with a median age of 42 and 45, respectively. The study was conducted by collecting the questionnaires in five nephrology centers. The questionnaire consisted of assessment of anxiety by using the Self-Rating Anxiety Scale and the influences of COVID-19, which included basic demographic data, the influences of COVID-19 on illness and daily life, as well as the patients' psychological responses during the epidemic.Results: A total of 612 patients were included and divided into two groups according to eGFR. Ninety-six patients (34%) in the CKD stage 1–2 group and 141 patients (42.7%) in the CKD stage 3–5 group had reduced their follow-up frequency (p = 0.031). More patients with CKD stages 1–2 consulted online (25.9%), p = 0.005. Besides, patients in the CKD stage 3–5 group tended to be more anxious about follow-up (p = 0.002), fearful of being infected with COVID-19 (p = 0.009), and more likely to feel symptoms getting worse (p = 0.006). The standard scores of SAS were 48.58 ± 7.082 and 51.19 ± 5.944 in the CKD stage 1–2 group and the CKD stage 3–5 group, respectively (p < 0.001). There were significant differences in the severity of anxiety (p = 0.004).Conclusion: COVID-19 had a greater impact on patients with CKD stages 3–5 than those with stages 1–2 in terms of illness, daily life, and psychological disorder. Patients with CKD stages 3–5 were more anxious during the COVID-19 pandemic.
format article
author Zheng Jiang
Zheng Jiang
Zheng Jiang
Jiang Liu
Jiang Liu
Lei Geng
Lei Geng
Zhengxia Zhong
Jiaxing Tan
Dongmei Wen
Ling Zhou
Yi Tang
Wei Qin
author_facet Zheng Jiang
Zheng Jiang
Zheng Jiang
Jiang Liu
Jiang Liu
Lei Geng
Lei Geng
Zhengxia Zhong
Jiaxing Tan
Dongmei Wen
Ling Zhou
Yi Tang
Wei Qin
author_sort Zheng Jiang
title The Influences of COVID-19 on Patients With Chronic Kidney Disease: A Multicenter Cross-Sectional Study
title_short The Influences of COVID-19 on Patients With Chronic Kidney Disease: A Multicenter Cross-Sectional Study
title_full The Influences of COVID-19 on Patients With Chronic Kidney Disease: A Multicenter Cross-Sectional Study
title_fullStr The Influences of COVID-19 on Patients With Chronic Kidney Disease: A Multicenter Cross-Sectional Study
title_full_unstemmed The Influences of COVID-19 on Patients With Chronic Kidney Disease: A Multicenter Cross-Sectional Study
title_sort influences of covid-19 on patients with chronic kidney disease: a multicenter cross-sectional study
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/f1bf1eba372b4244a2d602b3f52134a0
work_keys_str_mv AT zhengjiang theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT zhengjiang theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT zhengjiang theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT jiangliu theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT jiangliu theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT leigeng theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT leigeng theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT zhengxiazhong theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT jiaxingtan theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT dongmeiwen theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT lingzhou theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT yitang theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT weiqin theinfluencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT zhengjiang influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT zhengjiang influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT zhengjiang influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT jiangliu influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT jiangliu influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT leigeng influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT leigeng influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT zhengxiazhong influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT jiaxingtan influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT dongmeiwen influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT lingzhou influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT yitang influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
AT weiqin influencesofcovid19onpatientswithchronickidneydiseaseamulticentercrosssectionalstudy
_version_ 1718405937212948480